Report of a workshop: Interaction between oral contraceptives and essential dietary nutrients

Report of a workshop: Interaction between oral contraceptives and essential dietary nutrients

REPORT OF A WORKSHOP: INTERACTION BETWEEN ORAL CONTRACEPTIVES ESSENTIAL DIETARY Helmut Mueller, John J. Schrogie, AND NUTRIENTS M.D. M. D. Nat...

224KB Sizes 0 Downloads 16 Views

REPORT OF A WORKSHOP: INTERACTION

BETWEEN ORAL CONTRACEPTIVES

ESSENTIAL

DIETARY

Helmut Mueller, John J. Schrogie,

AND

NUTRIENTS

M.D. M. D.

National

Center for Population Research Institute of Child Health and Human Development Bethesda, Maryland

Accepted

for publication

September 27,

1971

CONTRACEPTION

A number oral

of

recent

contraceptive

a lesser

degree,

animals

and humans.

vitamin

BT2

relative

vitamin

of

stances

of vitamin

plasma

amino

importance.

which

have a marginal

Child

July

28,

Bethesda,

Maryland.

On

the

basis

populations tryptophan mately

75%

nutrients

of all

is too

cytes);

of

for

their

or tryptophan

small

is uncertain. Froportion

tryptophan fact,

ment of oral

*See

224

of

attached

studies

the

existing

serum

varies

40%

and essential

of

on the

intake.

the oral

basis of

The

effect

to be more common, users

tested.

of different

methodologies

in selected of

tissue

metabolites

and by means of acid

or

contraceptive tryptophan

users. brain

folic

requiring

Possible sarotonin

significance

essential results

(plasma,

status: erythro-

tests using

histidine

pathways,

respectively.

of

these

has been observed decrease

of

pro-

available

depressbn;

is useful

obser-

in a

in serotonin

decrease

and mental

Bo therapy

on

in approxi-

vitamin-dependent

loading

and subsequent

that vitamin

levels

location,

nutritional

compartments

anemia

acid

various

pyridoxine-dependent

oxygenase of

research.

oral contraceptives

assessing

or physiological

know-

and

contraceptive-using

These

standard

megaloblostic

body of

on the other

for

of

Heolth,

nutrients

being observed

Data

Institute of

geographical of

such generalizations.

have suggested

of

Institutes

that

contraceptive-associated

list

National

to survey

Regulating

National

it appears

may lead to depletion

several

met at the

data presented,

the folic

public

populations

by the Fertility

Research,

further

However,

of oml

convened

Population

for

determination

duced by induction

experts*

for

In many cases the biochemical vations

be paid to those

and priorities

formation;

these sub-

may have widespread

directions

levels

to assess

changes in the of

about

to permit

vitamin

quantitative

enzymes

of

was asked

contraceptive

limited

acid,

and an apparent

role

steroids

appears

are based on a number measurement

group

and dietary

metabolism

in

folic

status.

Center

effect

of

with

the fundamental

contraceptive

The

status

A and copper

of

and to

acids

levels

may be interrelated

none to more than

studied.

mcioeconomic

vitamin

of

Bo,

and amino

of

of the

in from

zinc

influences

vitamin

reduced

should

Development

The

important

acid,

include

such findings

a group

ledge on the interaction make recommendations

of

attention

Branch,

and Human

are decreased

levels

nutritional

1971,

folic

copper,

Because

Particular

Evaluation

Health

BT2,

Bg which

acids.

of

observed

biochemistry,

health

On

have suggested

vitamin

increased

in nutritional

Methods

A,

The effects

and zinc,

deficiency

pattern

publications

drugs on the metabolism

in the

in treat-

depression.

participants.

OCTOBER

1971 VOL. 4 NO. 4

CONTRACEPTION

On a more theoretical level, oral contraceptives may influence the formation of melanin and catecholamines by their influence on the folate-controlled, biopterine-dependent sequence of tyrosine metabolism leading to changes in skin pigmentation or cardiovascular dynamics, respectively. The low serum folate, elevated plasma homocystine levels and intravascular coagulation observed in cases of homocystinuria might represent a syndrome analogous to the problem of thromboembolism in oral contraceptive users. It was judged by the group that present knowledge of these metabolic abnormalities in oral contraceptive users does not warrant a recommendation for large-scale dietary supplementation at the present time. However, it was recommended that the problem be investigated comprehensively, with emphasis on nutrition surveys, to determine the prevalence and incidence of these effects in larger populations as well as on studies in animal models to improve understanding of the effects observed. Correlations between recognized adverse effects observed in oml contraceptive users and nutritional status should be investigated. A corollary of the program of investigation should include evaluation of the effects of the steroids on the quantity and quality of milk produced by nursing mothers using oral contraceptives for the prevention of further pregnancies. Other populations warranting particular attention are those women who become pregnant after discontinuation of oral contraceptives as well as those women resuming contraception after a pregnancy. Adverse effects resulting from drug-nutrient intemctions are likely to be amenable to practical preventive and corrective therapy and offer a unique opportunity for the study and control of adverse drug reactions. In addition, further exploration of oral contraceptive-nutrient interactions may form the basis for a more unified understanding of the pa&genesis of the presently bewildering spectrum of seemingly unrelated adverse effects attributed to these drugs.

OCTOBER

1971

VOL.

4 NO.

4

22s

CONTRACEPTION

Fertility

Regulating Center

National

Institute

PLANNING

of

SESSION:

Methods

Evaluation

for Population

Research

Child

Health

ORAL

CONTRACEPTIVES

ROSTER John

J.

Schrogie,

Chief,

Fertility for

National

Institute

and

Chairman

Evaluation

Population Human

Child

AND

VITAMINS

J.

Professor

and Choirman

McGanity,

Obstetrics

Health

of Obstetrics

University

of

Galveston, Dr.

M.D.

Arnold

of Clinic01

Oncology

Advisor

Division

of

Oncology

Pan American

of Wisconsin

Madison,

Wisconsin

C.E.

of

Director

David

B.

Director St.

Division School

Coursin,

Lancaster, 0.

St.

Boniface Boniface,

Executive

Secretary Institute

Rockville

Bethesda,

R.

Streiff,

of

Department New 1249 New

226

York

M.D. of

Medical

Science

Building

Medicine

Room M419 of

Gainesville,

Florida Florida

32601

17604 Mueller,

M.D.

Msficer of

Nutrition

Executive

20014

Fertility

Methods Center

Pike

Maryland

Leonard

Professor

Canada

Professor

National

Evalu&ion

for

Population Institute

and Human A.

Hospital

Manitoba,

Kline

American 9650

General

Assistant

University

Hospital

Lee

M.D.

Hematology

Hematology,

M.D.

Pennsylvanio

20037

Shojania, of

Orgonization

N.W.

D.C.

St.

Helmut Dr.

Street,

Majid

Richard 35233

of Research

Joseph’s

Surveillance

Health

of Medicine

South

Alabama

School

77550

Nutrition

23rd

Director

Medicine

7thAvenue

Birmingham,

A.

M.D.

of Alabama

525

in

Washington,

and

Nutrition

of

University 1919

Jr.,

Medicine

Deportment

School

53706

Butterworth,

Professor

Medical

8, Gynecology

Medical

Schaefer

R.

Rofessor University

Texas Texas

Raymond

Clinical

M.D. of

and Gynecology

Department

Development

Brown,

Development

William

Branch

Research

of

Human

PARTICIPANTS

Regulating

Methods Center

M.D.,

OF

and

Branch

Luhby,

Regulating

Branch Research

of Child

Health

Development

M.D.

Pediatrics of

Pediatrics

Medical

College

5th Avenue York,

New

York

lOc(L9

OCTOBER

1971

VOL. 4 NO. 4

CONTRACEPTION

SELECTED REFERENCES

Aly,

H.E.,

Donald, 86 metabolism.

Oral contraceptives E.A. and Simpson, M.H.: Amer. J. of Clin. Nutrition 24:25r7, 1971.

Baumblatt, M.J. and Winston, 1970, p. 832.

F.:

Pyridoxine

and the pill.

Lancet,

and vitamin

April

18,

Biochemistry and pathology of tryptophan metabolism and its Brown, R.R.: regulation by amino acids, vitamin B6, and steroid hormones. Amer. J. of Clin. Nutrition 24:243, 1971, Craft,

I.L., Wise, I., acid utilization.

Jr., and Briggs, M.H.: Oral contraceptives Amer. J. Obstet. Gynec. 108:1120, 1970.

and amino

Kahn,

S.B.,Fein, S., Rigberg, S. and Brodsky, I. : Correlation of Folate metabolism and socioeconomic status in pregnancy and in patients taking oral contraceptives. Amer. J. Obstet. Gynec. 108:931, 1970.

Luhby, A.L., Brin, M., Gordon, M., Davis, P., Murphy, M. and Spiegel, H.: Vitamin B6 metabolism in users of oml contraceptive agents. I. Abnormal urinary xanthurenic acid excretion and its correction by pyridoxine. Amer. J. of Clin. Nutrition 24:684, 1971. McLean, F.W., Heine, M.W., Held, B. and Streiff, R.R.: Relationship the oral contraceptive and folic acid metabolism. Amer. J. Obstet. 104:745, 1969. Necheles, T.F. and Snyder, L.M.: iated with oral contraceptive Price,

Streiff,

Malabsorption of folate palyglutamates assoctherapy. New Eng. J. of Med. 282:858, 1970.

Thornton, M.J. and Mueller, H .M.: J.M., using steroid hormones for ovulation control. 20:452, 1967.

The influence Rose, D.P.: Sci . 31-265, 1966. R. R. 214:105,

ond oral contraceptives.

J.

Amer.

Med.

Clin.

Assoc.

1970.

Schenker, J.G., Heilerstein, copper and zinc levels 22:229, 1971.

OCTOBER

Tryptophan metabolism in women Amer. J. of Clin. Nutrition

of oestrogens on tryptophan metabolism in man.

: Folate deficiency

between Gynec.

1971

VOL.

S., Jungreis, E. and Polishuk, W.Z.: in patients taking oral contraceptives.

4 NO. 4

Serum Fertil. Steril.

“27